Quiero saber acerca de...

41473

Federal Register / Vol. 86, No. 145 / Monday, August 2, 2021 / Notices e Assess information collection costs.
To request additional information on the proposed project or to obtain a copy of the information collection plan and instruments, call 404 6397570.
Comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular information collection by selecting Currently under 30-day ReviewOpen for Public Comments or by using the search function. Direct written comments and/or suggestions regarding the items contained in this notice to the Attention: CDC Desk Officer, Office of Management and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to 202 3955806. Provide written comments within 30 days of notice publication.
Proposed Project Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments CDCRFAPS212103
NewNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention NCHHSTP, Centers for Disease Control and Prevention CDC.
Background and Brief Description In 2021, CDC is implementing activities under a new cooperative agreement Integrated Viral Hepatitis Surveillance and Prevention Funding for Health Departments CDCRFA
PS212103. Tools exist to prevent new cases of hepatitis A, hepatitis B, and hepatitis C, to treat people living with hepatitis B, and to cure people living
with hepatitis C. Yet, new cases of viral hepatitis VH continue to rise, many people infected with VH remain undiagnosed, and far too many VHrelated deaths occur in the US each year. The purpose of the activities under this new cooperative agreement is to enable states to collect data to evaluate disease burden and trends, and to analyze and disseminate that data to develop or refine recommendations, policies, and practices that will ultimately reduce the burden of VH in their jurisdictions. The goals of the activities are to reduce new VH
infections, VH-related morbidity and mortality, and VH-related disparities, and to establish comprehensive national VH surveillance, which are in accordance with the Division of Viral Hepatitis 2025 Strategic Plan.
The activities of the new cooperative agreement are divided into two components Component 1:
Surveillance, and Component 2:
Prevention, containing six strategies:
1.1, develop, implement, and maintain a plan to rapidly detect and respond to outbreaks for hepatitis A, B, and C; 1.2, collect, analyze, interpret, and disseminate data to characterize trends, and implement public health interventions for hepatitis A, acute hepatitis B and acute and chronic hepatitis C; 1.3 contingent on available funding, collect, analyze, interpret, and disseminate data to characterize trends and implement public health interventions for chronic hepatitis B and perinatal hepatitis C; 2.1, support VH
elimination planning and surveillance, and maximize access to testing, treatment, and prevention; 2.2

Type of respondents
Health Health Health Health Health Health
Departments Departments Departments Departments Departments Departments
contingent on available funding, increase access to HCV and HBV testing and referral to care in high-impact settings; and 2.3 contingent on available funding, improve access to services preventing VH among persons who inject drugs. Contingent on funding, an optional component Component 3: Special Projects will support improved access to prevention, diagnosis, and treatment of viral, bacterial and fungal infections related to drug use in settings disproportionately affected by drug use.
Viral hepatitis case surveillance data will be collected per each jurisdictions usual mechanism using variables that have been approved by OMB separately OMB Control No. 09200728.
Performance measures will be monitored to assess recipient performance, including quality of data, effective program implementation, and accountability of funds. Data collection via the Annual Performance Report will be used for program accountability and to inform performance improvement.
Outbreak reporting will also be submitted throughout the year. These data, which complement case data as another key component of national viral hepatitis surveillance, are critical to determining both the level of viral hepatitis activity within a jurisdiction as well as the effectiveness of each jurisdictions approach to cluster and outbreak response.
CDC requests approval for an estimated 240 annual burden hours.
There is no cost to respondents other than their time.
Estimated Annualized Burden Hours Number of respondents
Form name

APR: Component 1
APR: Component 2
APR: Component 3
Initial Outbreak Report Form
Outbreak Summary Report Form
Acute Viral Hepatitis Case Reporting

59
59
14
59
59
59

khammond on DSKJM1Z7X2PROD with NOTICES

Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention.
FR Doc. 202116377 Filed 73021; 8:45 am BILLING CODE 416318P

VerDate Sep<11>2014

21:39 Jul 30, 2021

Jkt 253001

PO 00000

Frm 00041

Fmt 4703

Sfmt 4703

E:FRFM02AUN1.SGM

02AUN1

Number of responses per respondent 1
1 1
2 2
1

Average burden per response in hours 1
1 1
20/60
20/60
30/60